Croda International Share Price Falls 62% Today. Here’s Why.

July 31, 2024 10:35 AM PDT | By Team Kalkine Media

Google News:

Croda International Share Price Falls 62% Today. Here’s Why. — Image source: shutterstock.com

Recent News

Logistics Group Trends on NYSE Composite Despite Valuation Concerns

Institutional Interest High in MFA Financial Stock NYSE Composite

Dycom Industries Trading Near Peak After Recent Surge S&P 500

Archrock’s ROE Reflects Its Financial Health NYSE Composite

Croda International (LSE:CRDA), a chemicals company renowned for its high-quality products used in various industries, has seen its share price decline by 62% from its 2021 highs. The latest trading update initially painted a bleak picture, causing concern among investors. The company operates in sectors such as crop protection, beauty products, and life sciences, with the latter being a crucial part of its business.

Declining Sales in Life Sciences

A significant area of concern has been the performance of Croda's life sciences division. Sales in this segment dropped by 17.7% in the first half of 2024 compared to the last six months of 2023. This decline is partly attributed to a slowdown in lipid sales for COVID-19 vaccines, which accounted for £48 million at the end of last year. Excluding these sales, the drop is still 2%, suggesting that a return to previous levels may not be on the horizon.

This downturn in the life sciences segment is expected to impact the company's overall profitability for the year. Despite other divisions experiencing growth, operating income is projected to fall short of management's earlier expectations. This shortfall has contributed to the decline in the company's stock price.

Signs of Growth and Resilience

Despite the challenges, Croda International is not without its strengths. The company reported £881 million in revenues during the first half of 2023, which fell to £816 million in the first half of 2024, representing a 7% decline. However, this was largely due to a weak first quarter in 2024.

Encouragingly, Croda's sales have shown signs of recovery. In the last three months, the company generated £407.4 million in revenues, a 0.8% increase compared to the £404.2 million recorded in the second quarter of 2023.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.